Tejas Patil

17PUBLICATIONS
143CO-AUTHORS
Molecular targetsAutonomic nervous systemPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 18, 2026
Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non-Small Cell Lung Cancer.

|Mar 30, 2026
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers.

Emily A Miao, Beow Yeap, Sameh Daher

|Jan 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Sarah Waliany, Alissa J Cooper, Stephen V Liu

|Dec 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.

Tejas Patil, Jessica J Lin, Parneet K Cheema

|Jan 17, 2025
Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials.

David E Gerber, Claire R Wynters, Tanushree Prasad

|Jul 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).

Luke R G Pike, Emily Miao, Lillian A Boe

Pageof 3

Frequent Collaborators

3 joint publications

Shirish M Gadgeel

3 joint publications

Stephen V Liu

3 joint publications

Dara L Aisner

3 joint publications

Jessica J Lin